• 8 years ago
Merck Receives Approval of ZEPATIER™ (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review - http://dld.bz/em2kD

Category

🗞
News

Recommended

2:01
I
Up next
CHFA Reveals the Top Five New Natural Health Trends For 2016
CNW Group
0:51
BC companies pledge to change the Face of Leadership™ with The Minerva Foundation for BC Women
CNW Group
1:00
Kimberley Seldon: Happy Renovating!
CNW Group
0:13
Holiday Travel Tips to Help Families Through Security
CNW Group
0:37
Combined Heat and Power project at Campbell Canada
CNW Group
1:17
Michael "Pinball" Clemons tackles pneumococcal pneumonia
CNW Group
2:25
Commissionaires Services
CNW Group
0:31
There are many ways to thank veterans
CNW Group
1:08
Calling all mothers to participate in ONE DROP's online fundraising campaign
CNW Group
2:49
Canadian Society of Corporate Secretaries (CSCS) Announces Winners
CNW Group
2:54
Canadian Cheese Rolling Festival keeps growing
CNW Group
0:54
La campagne #golfcanadagolf r?unit les Canadiens
CNW Group
0:54
#GolfCanadaGolf Campaign Unites Canadians' Passion for Golf
CNW Group
2:28
Second Harvest Hero campaign
CNW Group
4:00
Simple Ways To Rethink Your Drink
CNW Group
0:30
Sparkling 7 Day Challenge
CNW Group
2:19
The Ultimate Weber Grills dock party
CNW Group
2:54
Canadians help save lives of vulnerable mothers and children
CNW Group
1:56
Toronto Pearson réaménagement de l'Aérogare 3
CNW Group
1:34
Toronto Pearson redevelopment of Terminal 3
CNW Group
1:05
Pfizer Préférence
CNW Group
1:05
Introducing the new Pfizer Préférence program
CNW Group
1:50
Introducing CNW’s Content Centre
CNW Group
0:15
Holiday Travel Tips to Help Families Through Security
CNW Group
0:34
Tested: The Best Meal Delivery Services for Easy Planning
Food and Wine